Version 1 of 1 (2003-12-17 to 2005-06-10) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.
Consultant lobbyist name: | KOBI DORENBUSH Lobbyist business address |
Consulting firm: |
MCDONALD & HAYDEN LLP
1 QUEEN STREET EAST, SUITE 1500 TORONTO, ON M5C 2Y3 Canada |
Position: | ASSOCIATE |
Telephone number: | 416-601-4160 |
Fax number: | 416-601-4100 |
Former public office holder: | N/A. Disclosure of this information was not a requirement prior to June 20, 2005. |
Payment is contingent on the success of the undertaking: | No |
Client: |
ONTARIO PHARMACEUTICAL EXPORT SUPPORT ORGANIZATION
14 JAMES STREET NORTH HAMILTON, ON L8R 2J9 Canada |
Telephone number: | 905-527-1716 |
Fax number: | 905-527-9978 |
Client Representative: |
HARVEY
ORGAN
|
Parent: | The client is not a subsidiary of any other parent companies. |
Coalition: | The client is not a coalition. |
Subsidiary: | The client does not have any subsidiaries that could be affected by the outcome of the undertaking. |
The following persons, corporations or organizations control or direct the activities and have a direct interest in their outcome: |
KOHLER'S DRUG STORE LIMITED
14 JAMES STREET NORTH HAMILTON, ON Canada L8R 2J9 ROGAN HOLDINGS CORPORATION 298 RUSSELL HILL ROAD TORONTO, ON Canada M4V 2T6 |
Was the client funded in whole or in part by any domestic or foreign government institution in the last completed financial year? | No |
Federal departments or organizations which have been or will be communicated with during the course of the undertaking: | Health Canada (HC), Patented Medicine Prices Review Board (PMPRB), Privy Council Office (PCO) | ||||||
Communication techniques that have been used or are expected to be used in the course of the undertaking:
|
Informal communications, Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format | ||||||
Subject Matter: Areas of Concern: | Health, International Trade | ||||||
Details Regarding the Identified Subject Matter
|